BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20172853)

  • 1. All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.
    Fernández-Calotti P; Pastor-Anglada M
    J Biol Chem; 2010 Apr; 285(18):13589-98. PubMed ID: 20172853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.
    Fernández-Calotti PX; Lopez-Guerra M; Colomer D; Pastor-Anglada M
    Haematologica; 2012 Jun; 97(6):943-51. PubMed ID: 22180426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
    Mackey JR; Galmarini CM; Graham KA; Joy AA; Delmer A; Dabbagh L; Glubrecht D; Jewell LD; Lai R; Lang T; Hanson J; Young JD; Merle-Béral H; Binet JL; Cass CE; Dumontet C
    Blood; 2005 Jan; 105(2):767-74. PubMed ID: 15454483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
    Tsang RY; Santos C; Ghosh S; Dabbagh L; King K; Young J; Cass CE; Mackey JR; Lai R
    Mod Pathol; 2008 Nov; 21(11):1387-93. PubMed ID: 18604194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures.
    Elwi AN; Damaraju VL; Kuzma ML; Baldwin SA; Young JD; Sawyer MB; Cass CE
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):289-301. PubMed ID: 18500522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
    King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
    Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.
    Paproski RJ; Yao SY; Favis N; Evans D; Young JD; Cass CE; Zemp RJ
    PLoS One; 2013; 8(2):e56423. PubMed ID: 23441192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
    Elwi AN; Damaraju VL; Kuzma ML; Mowles DA; Baldwin SA; Young JD; Sawyer MB; Cass CE
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1439-51. PubMed ID: 19297449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
    Molina-Arcas M; Marcé S; Villamor N; Huber-Ruano I; Casado FJ; Bellosillo B; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
    Leukemia; 2005 Jan; 19(1):64-8. PubMed ID: 15510196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.
    Errasti-Murugarren E; Cano-Soldado P; Pastor-Anglada M; Casado FJ
    Mol Pharmacol; 2008 Feb; 73(2):379-86. PubMed ID: 17993510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
    Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD
    Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different N-terminal motifs determine plasma membrane targeting of the human concentrative nucleoside transporter 3 in polarized and nonpolarized cells.
    Errasti-Murugarren E; Casado FJ; Pastor-Anglada M
    Mol Pharmacol; 2010 Nov; 78(5):795-803. PubMed ID: 20643903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
    Gupte A; Buolamwini JK
    Bioorg Med Chem Lett; 2009 Feb; 19(3):917-21. PubMed ID: 19097778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics.
    Smith KM; Slugoski MD; Loewen SK; Ng AM; Yao SY; Chen XZ; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2005 Jul; 280(27):25436-49. PubMed ID: 15870078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function.
    Fernández-Calotti P; Casulleras O; Antolin M; Guarner F; Pastor-Anglada M
    FASEB J; 2016 Feb; 30(2):544-54. PubMed ID: 26481311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.
    Mulinta R; Yao SYM; Ng AML; Cass CE; Young JD
    J Biol Chem; 2017 Jun; 292(23):9505-9522. PubMed ID: 28385889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.
    Errasti-Murugarren E; Molina-Arcas M; Casado FJ; Pastor-Anglada M
    FASEB J; 2009 Jan; 23(1):172-82. PubMed ID: 18827020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inward- and outward-facing homology modeling of human concentrative nucleoside transporter 3 (hCNT3) predicts an elevator-type transport mechanism.
    Yao SYM; Young JD
    Channels (Austin); 2018; 12(1):291-298. PubMed ID: 30096006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
    Errasti-Murugarren E; Molina-Arcas M; Casado FJ; Pastor-Anglada M
    Mol Pharmacol; 2010 Aug; 78(2):157-65. PubMed ID: 20421346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity.
    Wang C; Pimple S; Buolamwini JK
    Biochem Pharmacol; 2010 Feb; 79(3):307-20. PubMed ID: 19735647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.